Beyond LDL cholesterol, a new role for PCSK9.
Akram
Omar N
ON
Bernier
Adeline
A
Petrides
Francine
F
Wong
Gida
G
Lambert
Gilles
G
D000818:Animals; D050197:Atherosclerosis / Q000201:enzymology* / Q000235:genetics / Q000473:pathology; D002791:Cholesterol, Dietary / Q000097:blood; D008078:Cholesterol, LDL / Q000097:blood / Q000378:metabolism*; D015971:Gene Expression Regulation, Enzymologic; D020022:Genetic Predisposition to Disease; D006801:Humans; D006938:Hyperlipoproteinemia Type II / Q000201:enzymology* / Q000235:genetics / Q000473:pathology; D007421:Intestine, Small / Q000201:enzymology; D008099:Liver / Q000201:enzymology*; D051379:Mice; D009154:Mutation; D010641:Phenotype; D000071449:Proprotein Convertase 9; D043484:Proprotein Convertases; D011973:Receptors, LDL / Q000378:metabolism; D012697:Serine Endopeptidases / Q000235:genetics / Q000378:metabolism*; D014280:Triglycerides / Q000097:blood; D015854:Up-Regulation
D002791:Cholesterol, Dietary; D008078:Cholesterol, LDL; D011973:Receptors, LDL; D014280:Triglycerides; C472125:PCSK9 protein, human; D000071449:Proprotein Convertase 9; D043484:Proprotein Convertases; D012697:Serine Endopeptidases